Takeda Pharmaceutical Co. Ltd. - Total Other Finance Cost

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Total-Other-Finance-Cost" stands at 0.437 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the lowest value since 09/30/2024.'
Regarding the One-Year-Change of the series, the current value constitutes an decrease of -0.324 Billion Japanese Yens compared to the value the year prior.
The 1 year change is -0.324 Billion Japanese Yens.
The 3 year change is -37.88 Billion Japanese Yens.
The 5 year change is -16.29 Billion Japanese Yens.
The 10 year change is 40.90 Billion Japanese Yens.

The Serie's long term average value is -13.28 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 13.71 Billion Japanese Yens higher, compared to it's long term average value.
The Serie's change in Japanese Yens from it's minimum value, on 12/31/2018, to it's latest available value, on 09/30/2025, is +55.78 Billion.
The Serie's change in Japanese Yens from it's maximum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is -38.06 Billion.